88 Years old woman with acute muscular weakness and diffuse muscular pain: Have you thought about the drugs?;Faiblesse et douleurs musculaires généralisées chez une patiente de 88 ans: Avez-vous pensé aux médicaments?

Praxis

Volumn 99, Issue 24, 2010, Pages 1507-1511

  Arnold, Ch ^a   Lamy, Olivier ^a   Hagmann, N ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

CK; CYP3A4; Myopathy; Rhabdomyolysis; Statins

Indexed keywords

CLARITHROMYCIN; SIMVASTATIN; ANTIINFECTIVE AGENT; HYPOCHOLESTEROLEMIC AGENT;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; LUNG INFECTION; MUSCLE WEAKNESS; MYALGIA; RHABDOMYOLYSIS; RISK FACTOR; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; DRUG INTERACTION; PAIN;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTICHOLESTEREMIC AGENTS; CLARITHROMYCIN; DIAGNOSIS, DIFFERENTIAL; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MUSCLE WEAKNESS; PAIN; RHABDOMYOLYSIS; SIMVASTATIN;

EID: 78650216565     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/1661-8157/a000324     Document Type: Article

References (4)

1. Chatzizisis YS, Koskinas KC, Misirli G, Vaklavas C, Hatzitolios A, Giannoglou GD. Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy. Drug Safety 2010;33:171-187.
2. Wagner J, Suessmair C, Pfister H-W. Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin. J Neurol 2009;256:1182-1183.
3. Drug Interactions with Simvastatin. The Medical Letter 2008;50:83.
4. Molden E, Skovlund E, Braathen P. Risk Managment of Simvastatin or Atorvastatin Interactions with CYP3A4 Inhibitors. Drug Safety 2008;31:587-596. (Pubitemid 351861951)